Phibro Animal Health shareholders reelect three Class I directors and ratify PwC

PHIBRO ANIMAL HEALTH CORP

99.3% of voting power represented; Daniel M. Bendheim, Jonathan Bendheim, Sam Gejdenson elected to serve until 2026.
Director votes: Bendheim ~210.8M for, Bendheim ~210.4M for, Gejdenson ~206.7M for; 475k broker non-votes each.
Ratification of PwC as independent auditor for fiscal 2024 passed with 219.5M votes for, 878k against, 6.8k abstain.

item 5.07

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.95

PHIBRO ANIMAL HEALTH CORP shareholders approved Election of three Class I Directors at the 2023-11-06 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-11-06

Exact text from the filing

Director Nominee Votes For Votes Withheld Broker Non-Votes Daniel M. Bendheim 210,829,815 9,062,771 475,017 Jonathan Bendheim 210,428,372 9,464,214 475,017 Sam Gejdenson 206,715,662 13,176,924 475,017

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.95

PHIBRO ANIMAL HEALTH CORP shareholders approved Ratification of the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm at the 2023-11-06 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-11-06

Exact text from the filing

Votes For Votes Against Abstained 219,482,337 878,451 6,815 There were no broker non-votes on this proposal.

View on SEC.gov

Browse all shareholder votes →

PHIBRO ANIMAL HEALTH CORP filing history →

Source: SEC EDGAR

accession 0001104659-23-115253

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.